Clinical Trials Insight: 700020636
Latest Information Update: 13 Jan 2010
At a glance
- Drugs LX 6171 (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Adverse reactions
- Sponsors Lexicon Pharmaceuticals
- 01 Feb 2007 New trial record.